York University and Jazz Pharmaceuticals are undertaking a project to accelerate development of their Leukemia drug candidate. The project will take advantage of unique technologies developed at York by Drs. Wilson and Krylov, Millisecond Hydrogen Deuterium eXchange (msHDX) mass spectrometry and Kinetic Capillary Electrophoresis (KCE), to provide a high-detail picture of Jazz Pharmaceutical’s candidate, including […]
Read More